摘要:
The invention relates to polypeptides that bind to the oncogene product mdm2 and the uses of the identified polypeptides in therapeutic compositions to treat aberrant cell division in humans.
摘要:
The present invention discloses deuterated benzopyran compounds having structure features as shown in Formula (I), or pharmaceutically acceptable salts or stereoisomers thereof, or prodrug molecules thereof. With excellent anti-inflammatory and analgesic effects and the capability to inhibit growth of tumor cells, such compounds are novel COX-2 selective inhibitors. The compounds and pharmaceutically acceptable salts thereof disclosed by the present application can be applied in preparing anti-inflammatory and analgesic drugs and drugs for treating or preventing tumors.
摘要:
The present invention provides a mobile phone for authenticating Subscriber Identification Module (SIM) card and a SIM card authentication method adapted for the mobile phone. Once a SIM card is inserted into the mobile phone, the mobile phone acquires a phone number associated with the inserted SIM card and identifies whether the acquired phone number has been stored in the non-erasable programmable memory of the mobile phone. If yes, the user is legal and can use the mobile phone, if no, then the user is illegal and cannot use the mobile phone. Therefore, the mobile phone protects and hides stored information from the user.
摘要:
A computerized method determines similarities between a first image and a second image. The first image is converted into a first grayscale image, and the second image is converted into a second grayscale image, where a number of pixels of the second image is not less than a number of pixels of the first image. Each pixel of the first grayscale image is matched with a pixel of the second grayscale image to create a pixel pair sequence. A similarity value indicating the similarities between the first image and the second image is calculated according to the grayscale value of each pixel in the pixel pair sequence S.
摘要:
The invention is directed to methods and kits that allow for classification of non-small cell lung carcinoma tumors and cell lines according to genomic profiles, and methods of diagnosing, predicting clinical outcomes, and stratifying patient populations for clinical testing and treatment using the same.
摘要:
The present disclosure provides a webpage design system including a storage and a processor. The storage stores a number of ActiveX controls, a number of ActiveX control description files each describing a corresponding one ActiveX control, and a number of modules. The modules include instructions executable by the processor to provide a webpage interface for a user to design a webpage. The webpage interface includes an ActiveX control option for the user to select at least one desired ActiveX control. The modules further include instructions executable by the processor to position the selected ActiveX control in a designed webpage under construction, provide a search interface for the user to input a description of a desired function, and search in the ActiveX control description files according to the description to determine whether at least one ActiveX control having the desired function exists in the storage.
摘要:
Disclosed are methods for identifying early-stage non-small-cell lung cancer (NSCLC) patients who will have an unfavorable prognosis for the recurrence of lung cancer after surgical resection. The methods are based in part on the discovery that chromosomal copy number gains at Chr19, 34.7 Mb-35.6 Mb can be used for prognostic classification. The methods preferably use fluorescence in situ hybridization with fluorescently labeled nucleic acid probes to hybridize to patient samples to quantify the chromosomal copy number of this genetic locus.
摘要:
The present disclosure provides methods for identifying early stage non-small-cell lung cancer (NSCLC) patients who will have an unfavorable prognosis for the recurrence of lung cancer after surgical resection. The methods are based in part on the discovery of chromosomal copy number abnormalities that can be used for prognostic classification. The methods preferably use fluorescence in situ hybridization with fluorescently labeled nucleic acid probes to hybridize to patient samples to quantify the chromosomal copy number of these genetic loci.
摘要:
The invention is directed to methods and kits that allow for classification of non-small cell lung carcinoma tumors and cell lines according to genomic profiles, and methods of diagnosing, predicting clinical outcomes, and stratifying patient populations for clinical testing and treatment using the same.